Site-directed ligand discovery.

We report a strategy (called "tethering") to discover low molecular weight ligands ( approximately 250 Da) that bind weakly to targeted sites on proteins through an intermediary disulfide tether. A native or engineered cysteine in a protein is allowed to react reversibly with a small library of disulfide-containing molecules ( approximately 1,200 compounds) at concentrations typically used in drug screening (10 to 200 microM). The cysteine-captured ligands, which are readily identified by MS, are among the most stable complexes, even though in the absence of the covalent tether the ligands may bind very weakly. This method was applied to generate a potent inhibitor for thymidylate synthase, an essential enzyme in pyrimidine metabolism with therapeutic applications in cancer and infectious diseases. The affinity of the untethered ligand (K(i) approximately 1 mM) was improved 3,000-fold by synthesis of a small set of analogs with the aid of crystallographic structures of the tethered complex. Such site-directed ligand discovery allows one to nucleate drug design from a spatially targeted lead fragment.

[1]  Dustin J Maly,et al.  Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Pflugrath,et al.  The finer things in X-ray diffraction data collection. , 1999, Acta crystallographica. Section D, Biological crystallography.

[3]  Structure-based design of inhibitors specific for bacterial thymidylate synthase. , 1999, Biochemistry.

[4]  H. Jamil,et al.  An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. , 1998, Science.

[5]  R M Stroud,et al.  The additivity of substrate fragments in enzyme-ligand binding. , 1998, Structure.

[6]  Jean M. Severin,et al.  Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR , 1997 .

[7]  J. Lehn,et al.  Virtual combinatorial libraries: dynamic generation of molecular and supramolecular diversity by self-assembly. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Hajduk,et al.  Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.

[9]  J. Gut,et al.  Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum. , 1996, Molecular and biochemical parasitology.

[10]  G. Verdine,et al.  Deconstruction of GCN4/GCRE into a monomeric peptide-DNA complex , 1995, Nature Structural Biology.

[11]  D. Santi,et al.  The catalytic mechanism and structure of thymidylate synthase. , 1995, Annual review of biochemistry.

[12]  H. Gilbert,et al.  Thiol/disulfide exchange equilibria and disulfide bond stability. , 1995, Methods in enzymology.

[13]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[14]  D. Matthews,et al.  Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones. , 1993, Journal of medicinal chemistry.

[15]  I. Kuntz,et al.  Structure-based discovery of inhibitors of thymidylate synthase. , 1993, Science.

[16]  R. Stroud,et al.  Cofactor triggers the conformational change in thymidylate synthase: implications for an ordered binding mechanism. , 1992, Biochemistry.

[17]  S. Climie,et al.  Complete replacement set of amino acids at the C-terminus of thymidylate synthase: quantitative structure-activity relationship of mutants of an enzyme. , 1992, Biochemistry.

[18]  J. Knowles,et al.  Ligand recognition by influenza virus. The binding of bivalent sialosides. , 1991, The Journal of biological chemistry.

[19]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[20]  N. Xuong,et al.  Crystal structure of Escherichia coli thymidylate synthase containing bound 5-fluoro-2'-deoxyuridylate and 10-propargyl-5,8-dideazafolate. , 1990, Journal of molecular biology.

[21]  R M Stroud,et al.  Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate. , 1990, Biochemistry.

[22]  D. Santi,et al.  Bifunctional thymidylate synthase‐dihydrofolate reductase in protozoa , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  R. Stroud,et al.  Plastic adaptation toward mutations in proteins: Structural comparison of thymidylate synthases , 1990, Proteins.

[24]  P S Kim,et al.  Preferential heterodimer formation by isolated leucine zippers from fos and jun. , 1989, Science.

[25]  H. Daron,et al.  Inhibition of thymidylate synthase by pyridoxal phosphate. , 1989, The International journal of biochemistry.

[26]  D. L. Larson,et al.  Synthesis and opioid antagonist potencies of naltrexamine bivalent ligands with conformationally restricted spacers. , 1986, Journal of Medicinal Chemistry.

[27]  W. Jencks,et al.  On the attribution and additivity of binding energies. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Jackman,et al.  A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice. , 1981, European journal of cancer.

[29]  H. Daron,et al.  Kinetics of thymidylate synthase inhibition by disulfides. , 1980, Biochimica et biophysica acta.